Sun Pharma Seeks Recall Of Unapproved Phenobarbital Following Approval Of Its Product
Executive Summary
Since FDA has approved Sezaby there is no reason for continued use of unapproved phenobarbital sodium products, firm tells FDA. Sun cites risks to neonates from three excipients in these products. The seizure drug has been marketed since 1940.